Northwest Biotherapeutics Overview
- Founded
- 1996
- Status
- Public
- Employees
- 17
- Stock Symbol
- NWBO
- Investments
- 2
- Share Price
- $1.40
- (As of Tuesday Closing)
Northwest Biotherapeutics General Information
Description
Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. The target is a broad range of solid-tumor cancers. The company has a proprietary manufacturing technology, which it uses to produce a personalized vaccine. The product portfolio includes product candidates such as DCVax-L, for patients with brain cancer; DCVax-Direct, direct injection into all types of inoperable solid tumor cancers, and DCVax for late-stage ovarian cancer. DCVax-Prostate, for late-stage prostate cancer, has received clearance from the U.S. Food and Drug Administration.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
- 4800 Montgomery Lane
- Suite 800
- Bethesda, MD 20814
- United States
+1 (240) 000-0000
Northwest Biotherapeutics Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.40 | $1.45 | $0.17 - $2.51 | $1.18B | 842M | 1.92M | -$0.73 |
Northwest Biotherapeutics Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2020 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
|---|---|---|---|---|
| EV | 1,130,425 | 1,130,425 | 144,890 | 137,122 |
| Revenue | 1,291 | 1,291 | 2,410 | 412 |
| EBITDA | (520,852) | (520,852) | (17,837) | (24,632) |
| Net Income | (529,821) | (529,821) | (20,812) | (35,794) |
| Total Assets | 32,899 | 32,899 | 10,643 | 24,667 |
| Total Debt | 19,857 | 19,857 | 18,032 | 16,797 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Northwest Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Northwest Biotherapeutics‘s full profile, request access.
Request a free trialNorthwest Biotherapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. The target is a
Drug Discovery
Bethesda, MD
17
As of 2020
00000
000000000 -
00000
00000000
irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
0000 000000000
Boston, MA
0
As of 0000
00.000
000000000
00.000
0000000
do consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
0000 000000000
Bothell, WA
0000
As of 0000
00.000
000000000
00.000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialNorthwest Biotherapeutics Competitors (43)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | Corporation | Boston, MA | 0 | 00.000 | 000000000 | 00.000 |
| 0000000 00000000 | Formerly VC-backed | Bothell, WA | 0000 | 00.000 | 000000000 | 00.000 |
| 000 000000000000 | Formerly VC-backed | Epalinges, Switzerland | 000 | 00.000 | 00000000 | 00.000 |
| 000000 00000000000 | Venture Capital-Backed | Weston, FL | 0 | 000.00 | 00000000000 | 000.00 |
| 0000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 00000000 | 00000 |
Northwest Biotherapeutics Executive Team (7)
Northwest Biotherapeutics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 000000000 | Self | Director | 000 0000 |
Northwest Biotherapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNorthwest Biotherapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Northwest Biotherapeutics‘s full profile, request access.
Request a free trialNorthwest Biotherapeutics Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 | 28-Aug-2020 | 000000000000000000 | 00.00 | Therapeutic Devices | 00000 000000 00 |
| MithraGen | 01-Jan-2008 | Merger/Acquisition | Biotechnology |